share_log

长药控股(300391.SZ):前三季度净亏损1.81亿元

changjiang pharmaceutical group (300391.SZ): net loss of 0.181 billion yuan in the first three quarters.

Gelonghui Finance ·  Oct 29 05:41

Changjiang Pharmaceutical Group (300391.SZ) announced its third-quarter report for 2024 on October 29th, with the company achieving revenue of 0.101 billion yuan for the first three quarters, a year-on-year decrease of 90.12%; net income attributable to shareholders of the listed company was -0.181 billion yuan; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was -0.179 billion yuan; basic earnings per share was -0.5166 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment